All Stories

  1. Recent advances in the understanding and management of polycystic ovary syndrome
  2. Effect of letrozole in carcinogen-plus-estrogen-induced endometrial hyperplasia in mice
  3. Non-hormonal and hormonal intrauterine contraception: survey of patients’ perceptions in four Latin American countries
  4. Tratamento do sangramento uterino anormal: uma análise sob a perspectiva dos custos no Sistema Único de Saúde e da medicina suplementar
  5. Prospective Evaluation of a Panel of Plasma Cytokines and Chemokines as Potential Markers of Pelvic Endometriosis in Symptomatic Women
  6. LAP (produto da acumulação lipídica) e síndrome metabólica em pacientes com síndrome dos ovários policísticos
  7. Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus
  8. Increased expression of antimüllerian hormone and its receptor in endometriosis
  9. Angiogenesis and Endometriosis
  10. New trends for the medical treatment of endometriosis
  11. Altered expression of activin, cripto, and follistatin in the endometrium of women with endometrioma
  12. Impaired CRH and Urocortin Expression and Function in Eutopic Endometrium of Women with Endometriosis
  13. Chronotropic Incompetence and Abnormal Autonomic Modulation in Ambulatory Chagas Disease Patients
  14. Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease
  15. Faculty of 1000 evaluation for Designer TGFβ superfamily ligands with diversified functionality.
  16. Faculty of 1000 evaluation for Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study.
  17. Faculty of 1000 evaluation for Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.